GlassScriptPhysician profile
George Dillon
NPI 1598023665
$3,786.34
in general payments reported to CMS, 2019-2025
48 companies · $1,136 in 2025
The $1,136 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,086 · 2020: $270 · 2021: $30.97 · 2022: $13.34 · 2023: $15.74 · 2024: $235 · 2025: $1,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306 · Education: $79.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.45 |
| Education | $79.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $390.89 | 2019-2025 | Uplizna |
| Novartis Pharmaceuticals Corporation | $288.49 | 2019-2024 | |
| Lilly USA, LLC | $278.18 | 2019-2022 | |
| Genentech USA, INC. | $232.75 | 2019-2025 | Ocrevus Zunovo |
| Alnylam Pharmaceuticals INC. | $222.46 | 2019-2025 | Givlaari |
| Pfizer INC. | $197.93 | 2023-2025 | |
| Biogen, INC. | $178.75 | 2019-2025 | Vumerity, Skyclarys |
| Abbvie INC. | $153.83 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $146.42 | 2019-2025 | |
| Genzyme Corporation | $121.76 | 2019-2025 | |
| Emd Serono, INC. | $102.88 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $102.28 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $96.47 | 2025 | Hyqvia |
| Ucb, INC. | $92.42 | 2019-2025 | Fintepla, Rystiggo |
| Lundbeck LLC | $79.12 | 2019-2025 | Vyepti |
Show all 47 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.